UnknownNot Applicable

Cost-effectiveness of Extracorporeal Life Support Treatment

Netherlands200 participantsStarted 2017-12-01

Plain-language summary

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admitted to intensive care * Treated with extracorporeal life support Exclusion Criteria: * none

health related quality of life

Timeframe: 12 months

NCT IDNCT02837419

SponsorUniversity Medical Center Groningen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-01-01

Wim Dieperink, PhD